Form 4: Precipio Inc. CFO Matthew Gage Reports Stock Option Grant
SEC Form 4 Filing
Matthew Gage, CFO of Precipio Inc., reports the acquisition of stock options.
Summary
- On June 21, 2024, Matthew Gage, CFO of Precipio, Inc., acquired 4,000 stock options with an exercise price of $4.98.
- These options vest over time, with 25% vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments.
- Following the transaction, Gage directly owns 4,000 derivative securities.
- The options expire on June 21, 2034.
- The stock options were issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.
Sentiment
Score: 7
Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it aligns management incentives with shareholder value.
Positives
- The grant of stock options to the CFO aligns his interests with those of the shareholders.
- The vesting schedule incentivizes long-term commitment from the CFO.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
- The vesting schedule described (25% after one year, then monthly) is a typical arrangement to encourage long-term commitment.
- Comparable companies in the diagnostics and personalized medicine space, such as Exact Sciences or Guardant Health, also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning the CFO's interests with the company's long-term success.
- Employees may see this as a standard practice for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of stock option grant |
| 06/25/2024 | Date of Form 4 filing |
| 06/21/2034 | Expiration date of stock options |
Keywords
stock options, Form 4, Precipio, PRPO, CFO, Matthew Gage, equity incentive plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.